Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA yield is N/A as of Thursday, August 20, 2026.
EBITDA YIELD
N/A
Market Cap
$6.94B
EBITDA Yield
1.22%
TTM Avg
1.72%
3Y Avg
1.16%
5Y Avg
1.16%
Market Cap
$9.80B
EBITDA Yield
3.66%
TTM Avg
4.71%
3Y Avg
5.17%
5Y Avg
4.76%
| NAME | MARKET CAP | EBITDA YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Shoulder Innovations, Inc. (SI) | $482.37M | N/A | N/A | N/A | N/A |
| NRC Health (NRC)vs › | $495.36M | 4.10% | 7.05% | 7.36% | 6.54% |
| Teladoc Health, Inc. (TDOC)vs › | $1.21B | 6.95% | 3.37% | 1.58% | 1.58% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.21B | 19.92% | 13.56% | 5.72% | 6.67% |
| TransMedics Group, Inc. (TMDX)vs › | $3.25B | 2.80% | 2.87% | 2.13% | 2.13% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.94B | 1.22% | 1.72% | 1.16% | 1.16% |
| Oscar Health, Inc. (OSCR)vs › | $8.37B | 9.16% | 2.25% | 3.18% | 3.18% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.80B | 3.66% | 4.71% | 5.17% | 4.76% |
| Henry Schein, Inc. (HSIC)vs › | $10.17B | 7.84% | 8.67% | 8.48% | 8.64% |
| Universal Health Services, Inc. (UHS)vs › | $10.43B | 17.48% | 15.10% | 12.75% | 12.56% |
EBITDA Yield = TTM EBITDA / Enterprise Value
EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
